Table 3:
Comparison of procedural and clinical outcome after propensity score matching for primary and time-sensitivity analysisa
| Primary Analysis |
P Value | Time-Sensitivity Analysis |
P Value | |||
|---|---|---|---|---|---|---|
| ERIC (n = 57) | Non-ERIC (n = 57) | ERIC (n = 37) | Non-ERIC (n = 37) | |||
| TICI 2b–3 | 49 (86%) | 46 (81%) | 32 (86%) | 30 (81%) | ||
| OR (95% CI) | 1.46 (0.54–3.96) | .61 | 1.49 (0.43–5.22) | .75 | ||
| mRS 0–2 | 26 (46%) | 23 (40%) | 17 (46%) | 14 (38%) | ||
| OR (95% CI) | 1.24 (0.59–2.61) | .71 | 1.56 (0.62–3.93) | .64 | ||
| Mortality | 11 (19%) | 12 (21%) | 7 (19%) | 7 (19%) | ||
| OR (95% CI) | 0.90 (0.36–2.24) | 1.00 | 1.17 (0.39–3.45) | 1.00 | ||
| Procedural duration (min) | 67.4 | 98.0 | 74.1 | 90.8 | ||
| Mean difference (95% CI) | 30.6 (8.0–53.2) | .009 | 16.6 (−7.8–41.1) | .18 | ||
| No. of passes | 2.5 | 3.1 | 2.5 | 3.4 | ||
| Mean difference (95% CI) | 0.6 (−0.1–1.3) | .11 | 0.9 (−0.2–2.0) | .10 | ||
| Several devices needed | 10 (18%) | 22 (39%) | 7 (19%) | 16 (43%) | ||
| OR (95% CI) | 0.34 (0.14–0.80) | .02 | 0.31 (0.11–0.87) | .04 | ||
| Parenchymal hemorrhages | 4 (7%) | 8 (14%) | 4 (11%) | 2 (6%) | ||
| OR (95% CI) | 0.46 (0.13–1.63) | .36 | 1.50 (0.24–9.55) | .67 | ||
| Symptomatic hemorrhages | 3 (5%) | 9 (16%) | 3 (8%) | 4 (11%) | ||
| OR (95% CI) | 0.30 (0.076–1.16) | .12 | 0.47 (0.08–2.74) | 1.00 | ||
| Distal embolism | 1 (2%) | 5 (9%) | 1 (3%) | 4 (11%) | ||
| OR (95% CI) | 0.19 (0.02–1.64) | .21 | 0.23 (0.02–2.16) | .36 | ||
| Procedural adverse events | 16 (28%) | 17 (30%) | 11 (30%) | 13 (35%) | ||
| OR (95% CI) | 0.92 (0.41–2.06) | 1.00 | 0.59 (0.22–1.63) | .80 | ||
a
Data are No. (%) unless otherwise indicated.